過敏免疫療法市場規模、佔有率、成長分析，按治療類型、過敏類型、分銷管道、地區 - 行業預測，2024-2031

2022年全球過敏免疫治療市場規模將為20.7億美元，從2023年的22.6億美元成長到2031年的45億美元，預計在預測期內（2024-2031年）複合年成長率為9.0%。

全球過敏免疫治療市場按治療方法、過敏類型、分銷管道和地區細分。治療方法包括使用錠劑和滴劑的皮下免疫療法（SCIT）和舌下免疫療法（SLIT），過敏性疾病包括過敏性鼻炎和過敏性氣喘。透過線上平台和醫院、零售藥局等線下場所進行分銷，市場遍及北美、歐洲、亞太、中東和非洲以及拉丁美洲。據估計，世界上有 10-30% 的人口患有各種過敏症，對免疫療法的需求正在增加。促進市場擴張的因素包括工業成長、醫療保健的進步以及由口腔溶解片等創新產品的監管核准推動的新治療方法的推出。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步

過敏免疫治療市場規模：依治療類型及複合年成長率（2024-2031）

• 市場概況
• 皮下免疫治療
• 舌下免疫治療

按類型分類的過敏免疫治療市場規模和複合年成長率（2024-2031）

• 市場概況
• 藥片
• 降低

過敏免疫治療市場規模：依過敏類型及複合年成長率（2024-2031）

• 市場概況
• 過敏性鼻炎
• 過敏性氣喘
• 其他

過敏免疫治療市場規模：按分銷管道和複合年成長率（2024-2031）

• 市場概況
• 醫院藥房
• 零售藥房
• 網路藥房

過敏免疫治療市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• ALK-Abello
• Allergy Therapeutics
• Anergis SA
• ASIT biotech
• DBV Technologies
• HAL Allergy Group
• Hymenoptera Immunotherapy Group
• Immunomic Therapeutics, Inc.
• Laboratorios LETI
• Merck KGaA
• Novartis International AG
• Stallergenes Greer plc
• Tunitas Therapeutics, Inc.
• VentiRx Pharmaceuticals
• Biomay AG
• Genentech, Inc.
• GlaxoSmithKline plc
• Meda AB
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.

結論和建議

Global Allergy Immunotherapy Market size was valued at USD 2.07 billion in 2022 and is poised to grow from USD 2.26 billion in 2023 to USD 4.5 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2024-2031).

The global Allergy Immunotherapy Market is categorized by treatment methods, types of allergies, distribution channels, and geographical regions. Treatment options include Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) through tablets and drops, while allergic conditions encompass allergic rhinitis, allergic asthma, and others. Distribution occurs through online platforms and offline venues, including hospital and retail pharmacies, and the market spans North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. With an estimated 10-30% of the global population affected by various allergies, the demand for immunotherapy is growing. Factors driving market expansion include industrial growth, advancements in healthcare, and the introduction of new therapies, bolstered by regulatory approvals for innovative products like oral dissolvable tablets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Immunotherapy Market Segmental Analysis

Global Allergy Immunotherapy Market is segmented by treatment type, type, allergy type, distribution channel and region. Based on treatment type, the market is segmented into subcutaneous immunotherapy and sublingual immunotherapy. Based on type, the market is segmented into tablets and drops. Based on allergy type, the market is segmented into allergic rhinitis, allergic asthma and others. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is primarily driven by the escalating incidence of allergies, which has created a pressing need for effective treatment options. The increasing cases of various allergies, along with the advent of novel sublingual immunotherapies, particularly in developing countries, are significantly propelling market growth. In the U.S., allergies rank as the sixth most prevalent chronic condition, impacting over 50 million individuals and incurring annual costs exceeding USD 18 billion, according to the American College of Allergy, Asthma & Immunology. Furthermore, the rising prevalence of food allergies among both children and adults worldwide is anticipated to further boost the demand for advanced immunotherapy solutions.

Restraints in the Global Allergy Immunotherapy Market

The global allergy immunotherapy market faces significant challenges due to several restraints. Primarily, the cutting-edge technology employed in allergy immunotherapy necessitates regular maintenance, which demands specialized professional expertise, thereby driving up routine maintenance costs. As a result, operational expenses are expected to increase, posing a substantial hurdle to market growth. Furthermore, there is a pressing need to enhance awareness and understanding of this advanced therapeutic approach across various sectors. The lack of familiarity with innovative technological advancements may act as an additional barrier to the market's development, hindering its potential expansion and limiting patient access to effective treatments.

Market Trends of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is witnessing a significant upward trend driven by advancements in technology, particularly in high-resolution analysis of rare cells within local tissues. These innovations have facilitated the identification of precise and reliable biomarkers for monitoring allergy immunotherapy, enhancing treatment efficacy and personalizing patient care. As healthcare providers increasingly adopt these cutting-edge analytical techniques, the market is expected to expand rapidly, fostering the development of targeted therapies and improving patient compliance. Additionally, the growing prevalence of allergic conditions and rising awareness regarding effective treatment options further bolster market growth, positioning allergy immunotherapy as a vital component of modern allergy management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Allergy Immunotherapy Market Size by Treatment Type & CAGR (2024-2031)

• Market Overview
• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

Global Allergy Immunotherapy Market Size by Type & CAGR (2024-2031)

• Market Overview
• Tablets
• Drops

Global Allergy Immunotherapy Market Size by Allergy Type & CAGR (2024-2031)

• Market Overview
• Allergic Rhinitis
• Allergic Asthma
• Others

Global Allergy Immunotherapy Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Allergy Immunotherapy Market Size & CAGR (2024-2031)

• North America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • USA
  • Canada
• Europe (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Type, Allergy Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Type, Allergy Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• ALK-Abello
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergy Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anergis SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ASIT biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DBV Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HAL Allergy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hymenoptera Immunotherapy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunomic Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios LETI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunitas Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VentiRx Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomay AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meda AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations